Multivalent Vaccines Market - Global Outlook and Forecast 2021-2027

Code: RW00014560505
Market Monitor Global
Oct-2021
Life Sciences
101 Pages

This report contains market size and forecasts of Multivalent Vaccines in global, including the following market information:
Global Multivalent Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Multivalent Vaccines Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Multivalent Vaccines companies in 2020 (%)
The global Multivalent Vaccines market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multivalent Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multivalent Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Multivalent Vaccines Market Segment Percentages, By Type, 2020 (%)
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines

Global Multivalent Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Multivalent Vaccines Market Segment Percentages, By Application, 2020 (%)
Pediatrics
Adults

Global Multivalent Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Multivalent Vaccines Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multivalent Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Multivalent Vaccines revenues share in global market, 2020 (%)
Key companies Multivalent Vaccines sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Multivalent Vaccines sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline, plc (U.K.)
Pfizer, Inc (US)
Merck & Co., Inc (US)
Sanofi Pasteur SA (France)
Astellas Pharma Inc. (Japan)
CSL Limited (Australia)
Emergent BioSolutions, Inc (US)
Johnson & Johnson (US)
MedImmune, LLC (US)
Serum Institute of India Pvt. Ltd. (India)
Bavarian Nordic (Denmark)
Mitsubishi Tanabe Pharma Corporation (Japan)
Daiichi Sankyo (Japan)
Protein Sciences Corporation (US)
Panacea Biotec (India)

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Multivalent Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multivalent Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multivalent Vaccines Overall Market Size
2.1 Global Multivalent Vaccines Market Size: 2021 VS 2027
2.2 Global Multivalent Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Multivalent Vaccines Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Multivalent Vaccines Players in Global Market
3.2 Top Global Multivalent Vaccines Companies Ranked by Revenue
3.3 Global Multivalent Vaccines Revenue by Companies
3.4 Global Multivalent Vaccines Sales by Companies
3.5 Global Multivalent Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Multivalent Vaccines Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Multivalent Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Multivalent Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Multivalent Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Multivalent Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Multivalent Vaccines Market Size Markets, 2021 & 2027
4.1.2 Conjugate Vaccines
4.1.3 Inactivated and Subunit Vaccines
4.1.4 Live Attenuated Vaccines
4.1.5 Toxoid Vaccines
4.1.6 Recombinant Vaccines
4.2 By Type - Global Multivalent Vaccines Revenue & Forecasts
4.2.1 By Type - Global Multivalent Vaccines Revenue, 2016-2021
4.2.2 By Type - Global Multivalent Vaccines Revenue, 2022-2027
4.2.3 By Type - Global Multivalent Vaccines Revenue Market Share, 2016-2027
4.3 By Type - Global Multivalent Vaccines Sales & Forecasts
4.3.1 By Type - Global Multivalent Vaccines Sales, 2016-2021
4.3.2 By Type - Global Multivalent Vaccines Sales, 2022-2027
4.3.3 By Type - Global Multivalent Vaccines Sales Market Share, 2016-2027
4.4 By Type - Global Multivalent Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Multivalent Vaccines Market Size, 2021 & 2027
5.1.2 Pediatrics
5.1.3 Adults
5.2 By Application - Global Multivalent Vaccines Revenue & Forecasts
5.2.1 By Application - Global Multivalent Vaccines Revenue, 2016-2021
5.2.2 By Application - Global Multivalent Vaccines Revenue, 2022-2027
5.2.3 By Application - Global Multivalent Vaccines Revenue Market Share, 2016-2027
5.3 By Application - Global Multivalent Vaccines Sales & Forecasts
5.3.1 By Application - Global Multivalent Vaccines Sales, 2016-2021
5.3.2 By Application - Global Multivalent Vaccines Sales, 2022-2027
5.3.3 By Application - Global Multivalent Vaccines Sales Market Share, 2016-2027
5.4 By Application - Global Multivalent Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Multivalent Vaccines Market Size, 2021 & 2027
6.2 By Region - Global Multivalent Vaccines Revenue & Forecasts
6.2.1 By Region - Global Multivalent Vaccines Revenue, 2016-2021
6.2.2 By Region - Global Multivalent Vaccines Revenue, 2022-2027
6.2.3 By Region - Global Multivalent Vaccines Revenue Market Share, 2016-2027
6.3 By Region - Global Multivalent Vaccines Sales & Forecasts
6.3.1 By Region - Global Multivalent Vaccines Sales, 2016-2021
6.3.2 By Region - Global Multivalent Vaccines Sales, 2022-2027
6.3.3 By Region - Global Multivalent Vaccines Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Multivalent Vaccines Revenue, 2016-2027
6.4.2 By Country - North America Multivalent Vaccines Sales, 2016-2027
6.4.3 US Multivalent Vaccines Market Size, 2016-2027
6.4.4 Canada Multivalent Vaccines Market Size, 2016-2027
6.4.5 Mexico Multivalent Vaccines Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Multivalent Vaccines Revenue, 2016-2027
6.5.2 By Country - Europe Multivalent Vaccines Sales, 2016-2027
6.5.3 Germany Multivalent Vaccines Market Size, 2016-2027
6.5.4 France Multivalent Vaccines Market Size, 2016-2027
6.5.5 U.K. Multivalent Vaccines Market Size, 2016-2027
6.5.6 Italy Multivalent Vaccines Market Size, 2016-2027
6.5.7 Russia Multivalent Vaccines Market Size, 2016-2027
6.5.8 Nordic Countries Multivalent Vaccines Market Size, 2016-2027
6.5.9 Benelux Multivalent Vaccines Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Multivalent Vaccines Revenue, 2016-2027
6.6.2 By Region - Asia Multivalent Vaccines Sales, 2016-2027
6.6.3 China Multivalent Vaccines Market Size, 2016-2027
6.6.4 Japan Multivalent Vaccines Market Size, 2016-2027
6.6.5 South Korea Multivalent Vaccines Market Size, 2016-2027
6.6.6 Southeast Asia Multivalent Vaccines Market Size, 2016-2027
6.6.7 India Multivalent Vaccines Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Multivalent Vaccines Revenue, 2016-2027
6.7.2 By Country - South America Multivalent Vaccines Sales, 2016-2027
6.7.3 Brazil Multivalent Vaccines Market Size, 2016-2027
6.7.4 Argentina Multivalent Vaccines Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Multivalent Vaccines Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Multivalent Vaccines Sales, 2016-2027
6.8.3 Turkey Multivalent Vaccines Market Size, 2016-2027
6.8.4 Israel Multivalent Vaccines Market Size, 2016-2027
6.8.5 Saudi Arabia Multivalent Vaccines Market Size, 2016-2027
6.8.6 UAE Multivalent Vaccines Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline, plc (U.K.)
7.1.1 GlaxoSmithKline, plc (U.K.) Corporate Summary
7.1.2 GlaxoSmithKline, plc (U.K.) Business Overview
7.1.3 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.1.5 GlaxoSmithKline, plc (U.K.) Key News
7.2 Pfizer, Inc (US)
7.2.1 Pfizer, Inc (US) Corporate Summary
7.2.2 Pfizer, Inc (US) Business Overview
7.2.3 Pfizer, Inc (US) Multivalent Vaccines Major Product Offerings
7.2.4 Pfizer, Inc (US) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.2.5 Pfizer, Inc (US) Key News
7.3 Merck & Co., Inc (US)
7.3.1 Merck & Co., Inc (US) Corporate Summary
7.3.2 Merck & Co., Inc (US) Business Overview
7.3.3 Merck & Co., Inc (US) Multivalent Vaccines Major Product Offerings
7.3.4 Merck & Co., Inc (US) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.3.5 Merck & Co., Inc (US) Key News
7.4 Sanofi Pasteur SA (France)
7.4.1 Sanofi Pasteur SA (France) Corporate Summary
7.4.2 Sanofi Pasteur SA (France) Business Overview
7.4.3 Sanofi Pasteur SA (France) Multivalent Vaccines Major Product Offerings
7.4.4 Sanofi Pasteur SA (France) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.4.5 Sanofi Pasteur SA (France) Key News
7.5 Astellas Pharma Inc. (Japan)
7.5.1 Astellas Pharma Inc. (Japan) Corporate Summary
7.5.2 Astellas Pharma Inc. (Japan) Business Overview
7.5.3 Astellas Pharma Inc. (Japan) Multivalent Vaccines Major Product Offerings
7.5.4 Astellas Pharma Inc. (Japan) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.5.5 Astellas Pharma Inc. (Japan) Key News
7.6 CSL Limited (Australia)
7.6.1 CSL Limited (Australia) Corporate Summary
7.6.2 CSL Limited (Australia) Business Overview
7.6.3 CSL Limited (Australia) Multivalent Vaccines Major Product Offerings
7.6.4 CSL Limited (Australia) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.6.5 CSL Limited (Australia) Key News
7.7 Emergent BioSolutions, Inc (US)
7.7.1 Emergent BioSolutions, Inc (US) Corporate Summary
7.7.2 Emergent BioSolutions, Inc (US) Business Overview
7.7.3 Emergent BioSolutions, Inc (US) Multivalent Vaccines Major Product Offerings
7.4.4 Emergent BioSolutions, Inc (US) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.7.5 Emergent BioSolutions, Inc (US) Key News
7.8 Johnson & Johnson (US)
7.8.1 Johnson & Johnson (US) Corporate Summary
7.8.2 Johnson & Johnson (US) Business Overview
7.8.3 Johnson & Johnson (US) Multivalent Vaccines Major Product Offerings
7.8.4 Johnson & Johnson (US) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.8.5 Johnson & Johnson (US) Key News
7.9 MedImmune, LLC (US)
7.9.1 MedImmune, LLC (US) Corporate Summary
7.9.2 MedImmune, LLC (US) Business Overview
7.9.3 MedImmune, LLC (US) Multivalent Vaccines Major Product Offerings
7.9.4 MedImmune, LLC (US) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.9.5 MedImmune, LLC (US) Key News
7.10 Serum Institute of India Pvt. Ltd. (India)
7.10.1 Serum Institute of India Pvt. Ltd. (India) Corporate Summary
7.10.2 Serum Institute of India Pvt. Ltd. (India) Business Overview
7.10.3 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Major Product Offerings
7.10.4 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.10.5 Serum Institute of India Pvt. Ltd. (India) Key News
7.11 Bavarian Nordic (Denmark)
7.11.1 Bavarian Nordic (Denmark) Corporate Summary
7.11.2 Bavarian Nordic (Denmark) Multivalent Vaccines Business Overview
7.11.3 Bavarian Nordic (Denmark) Multivalent Vaccines Major Product Offerings
7.11.4 Bavarian Nordic (Denmark) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.11.5 Bavarian Nordic (Denmark) Key News
7.12 Mitsubishi Tanabe Pharma Corporation (Japan)
7.12.1 Mitsubishi Tanabe Pharma Corporation (Japan) Corporate Summary
7.12.2 Mitsubishi Tanabe Pharma Corporation (Japan) Multivalent Vaccines Business Overview
7.12.3 Mitsubishi Tanabe Pharma Corporation (Japan) Multivalent Vaccines Major Product Offerings
7.12.4 Mitsubishi Tanabe Pharma Corporation (Japan) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.12.5 Mitsubishi Tanabe Pharma Corporation (Japan) Key News
7.13 Daiichi Sankyo (Japan)
7.13.1 Daiichi Sankyo (Japan) Corporate Summary
7.13.2 Daiichi Sankyo (Japan) Multivalent Vaccines Business Overview
7.13.3 Daiichi Sankyo (Japan) Multivalent Vaccines Major Product Offerings
7.13.4 Daiichi Sankyo (Japan) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.13.5 Daiichi Sankyo (Japan) Key News
7.14 Protein Sciences Corporation (US)
7.14.1 Protein Sciences Corporation (US) Corporate Summary
7.14.2 Protein Sciences Corporation (US) Business Overview
7.14.3 Protein Sciences Corporation (US) Multivalent Vaccines Major Product Offerings
7.14.4 Protein Sciences Corporation (US) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.14.5 Protein Sciences Corporation (US) Key News
7.15 Panacea Biotec (India)
7.15.1 Panacea Biotec (India) Corporate Summary
7.15.2 Panacea Biotec (India) Business Overview
7.15.3 Panacea Biotec (India) Multivalent Vaccines Major Product Offerings
7.15.4 Panacea Biotec (India) Multivalent Vaccines Sales and Revenue in Global (2016-2021)
7.15.5 Panacea Biotec (India) Key News
8 Global Multivalent Vaccines Production Capacity, Analysis
8.1 Global Multivalent Vaccines Production Capacity, 2016-2027
8.2 Multivalent Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Multivalent Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Multivalent Vaccines Supply Chain Analysis
10.1 Multivalent Vaccines Industry Value Chain
10.2 Multivalent Vaccines Upstream Market
10.3 Multivalent Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Multivalent Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Multivalent Vaccines in Global Market
Table 2. Top Multivalent Vaccines Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Multivalent Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Multivalent Vaccines Revenue Share by Companies, 2016-2021
Table 5. Global Multivalent Vaccines Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Multivalent Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Multivalent Vaccines Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Multivalent Vaccines Product Type
Table 9. List of Global Tier 1 Multivalent Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multivalent Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

GlaxoSmithKline, plc (U.K.)
Pfizer, Inc (US)
Merck & Co., Inc (US)
Sanofi Pasteur SA (France)
Astellas Pharma Inc. (Japan)
CSL Limited (Australia)
Emergent BioSolutions, Inc (US)
Johnson & Johnson (US)
MedImmune, LLC (US)
Serum Institute of India Pvt. Ltd. (India)
Bavarian Nordic (Denmark)
Mitsubishi Tanabe Pharma Corporation (Japan)
Daiichi Sankyo (Japan)
Protein Sciences Corporation (US)
Panacea Biotec (India)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE